Ayala Pharmaceuticals Presents Preliminary Clinical Data from the Ongoing Phase 2 ACCURACY Trial and Announces Pre-Clinical Proof of Concept Data for Enhanced Activity of AL101 in Combination with Approved Cancer Therapies in ACC

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access